Lake Pharma Acquires Blue Sky
LakePharma, Inc., the leading provider of integrated solutions covering the biologics CRO space, has acquired Blue Sky BioServices. The combined company will be known as LakePharma, and is now the largest dedicated biologics CRO in the United States. The combination brings together LakePharma’s world class expertise in antibody development, protein expression and characterization, molecular biology and process development with Blue Sky’s leadership in bacterial and baculovirus systems, complementary molecular biology platforms, and assay services. LakePharma has nearly 100 employees in the San Francisco Bay Area and Cambridge/Boston.
Learn More»
Now Hiring
Blue Sky Bioservices is now part of LakePharma. Please visit lakepharma.com//job-openings to view current openings for LakePharma Worcester.
Latest News
SAN FRANCISCO & BELMONT, Calif.--(BUSINESS WIRE)--Trianni, Inc., (TRIANNI) a private biotech company developing novel antibody discovery platforms, and LakePharma, Inc., the leading contract research organization (CRO) offering integrated solutions for biologics discovery and development, today announced a technology partnership to empower antibody drug development. The agreement grants LakePharma the right to utilize the Trianni Mouse Platform for antibody discovery services. LakePharma will be responsible for marketing the Trianni Platform as part of its service offerings in the US. Financial terms were not disclosed.
more»
